Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma.
Journal: Neuro-oncology
Published: August 28, 2025
Cavity-mediated enhancement of CISS in DNA junctions.
Journal: Physical chemistry chemical physics : PCCP
Published: August 07, 2025
PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation.
Journal: The Journal of clinical investigation
Published: March 13, 2025
Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers.
Journal: Cancer discovery
Published: August 27, 2024
Targeting TGFβ docking receptor Glycoprotein A Repetitions Predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastoma.
Journal: Neuro-oncology
Published: July 17, 2024
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer.
Journal: Journal for immunotherapy of cancer
Published: November 23, 2023
Liouvillian exceptional points of an open driven two-level system.
Journal: The Journal of chemical physics
Published: September 23, 2023
Exceptional points treatment of cavity spectroscopies.
Journal: The Journal of chemical physics
Published: January 10, 2023
Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: August 16, 2022
Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer.
Journal: Science immunology
Published: April 14, 2022
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.
Journal: Journal of hematology & oncology
Published: November 15, 2021
TREATMENT WITH SOLUBLE CD24 ATTENUATES COVID-19-ASSOCIATED SYSTEMIC IMMUNOPATHOLOGY.
Journal: medRxiv : the preprint server for health sciences
Published: August 31, 2021
Last Updated: 09/26/2026